18F-FDG PET/CT technology for the assessment of brown adipose tissue: an updated review

M. Ricci,V. Frantellizzi,A. Cimini,B. Carabellese,M. S. de Feo,E. Lubrano,Giorgia Maria Granese
DOI: https://doi.org/10.1080/17434440.2023.2283618
IF: 3.439
2023-11-15
Expert Review of Medical Devices
Abstract:ABSTRACT Introduction This review provides an update of 18 F-fluorodeoxyglucose ([18F] FDG) for Brown adipose tissue (BAT) activity quantification, whose role is not completely understood. Areas covered We conducted an unstructured search of the literature for any studies employing the [18F] FDG PET in BAT assessment. We explored BAT quantification both in healthy individuals and in different pathologies, after cold exposure and as a metabolic biomarker. The assessment of possible BAT modulators by using [18F] FDG PET is shown. Further PET tracers and novel developments for BAT assessments are also described. Expert opinion Further PET tracers and imaging modalities are under investigation, but the [18F] FDG PET is currently the method of choice for the evaluation of BAT and further multicentric trials are needed for a better understanding of the BAT physiopathology, also after cold stimuli. The modulation of BAT activity, assessed by [18F] FDG PET imaging, seems a promising tool for the management of conditions such as obesity and type 2 diabetes. Moreover, an interesting possible correlation of BAT activation with prognostic [18F] FDG PET indices in cancer patients should be assessed with further multicentric trials.
Medicine
What problem does this paper attempt to address?